Aberdare Ventures

Aberdare Ventures, established in 1999 and based in San Francisco, California, was a prominent venture capital firm exclusively dedicated to the healthcare sector. The firm historically invested across various stages, from seed and early-stage ventures to later-stage growth companies. However, it is crucial to note that Aberdare Ventures is no longer making new investments, having transitioned to managing its existing portfolio.

Throughout its active investment period, Aberdare Ventures sought out innovative companies poised to transform healthcare delivery and outcomes. Their investment thesis spanned biotechnology, medical devices, diagnostics, and healthcare IT. Historically, the firm's typical first cheque sizes ranged significantly, generally falling between $5 million and $20 million, demonstrating their flexibility in supporting companies from initial growth phases through more mature development.

Over its operational history, Aberdare Ventures successfully raised substantial capital, totaling over $1 billion across five distinct funds. Their final fund, Aberdare Ventures V, L.P., closed in 2014 with a committed capital of $200 million. This significant capital base allowed the firm to make impactful investments in numerous companies, contributing to advancements in the healthcare landscape. While no longer deploying new capital, their legacy includes a portfolio of companies that have achieved significant milestones and exits.